Skip to main content
. 2019 May 15;10:2042098619847420. doi: 10.1177/2042098619847420

Figure 2.

Figure 2.

Awareness of risks associated with golimumab among golimumab prescribers for all surveyed countries and all specialties combined, presented by survey year (e.g. 2010, 2012, 2014, and 2016 surveys). Data are shown as a percentage of the total number of golimumab prescriber healthcare professionals surveyed (N = 195, 243, 393, and 439 for 2010, 2012, 2014, and 2016, respectively).

CHF, congestive heart failure; GLM, golimumab; HBV, hepatitis B virus; HCPs, healthcare professionals; PAC, patient alert card; pts, patients; TB, tuberculosis.